Impact of intracoronary adenosine administration during primary PCI: A meta-analysis

International Journal of Cardiology

Volumn 203, Issue , 2016, Pages 1032-1041

  Polimeni, Alberto ^a   De Rosa, Salvatore ^a   Sabatino, Jolanda ^a   Sorrentino, Sabato ^a   Indolfi, Ciro ^a,b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

Intracoronary adenosine; Meta analysis; No reflow; STEMI

Indexed keywords

ADENOSINE; PLACEBO; VASODILATOR AGENT;

ARTICLE; CORRELATION ANALYSIS; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INTRACORONARY DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT RESPONSE; CORONARY BLOOD VESSEL; DRUG EFFECTS; FEMALE; HEART MUSCLE REPERFUSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES;

ADENOSINE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASODILATOR AGENTS;

EID: 84952700822     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.11.086     Document Type: Article

References (43)

1. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey, M.K. Chung, J.A. de Lemos, and et al. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines J. Am. Coll. Cardiol. 61 2013 e78 e140 10.1016/j.jacc.2012.11.019
2. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J. Am. Coll. Cardiol. 54 2009 281 292
3. S. De Rosa, P. Cirillo, G. De Luca, G. Galasso, G. Esposito, D. Leosco, and et al. Rheolytic thrombectomy during percutaneous coronary intervention improves long-term outcome in high-risk patients with acute myocardial infarction J. Interv. Cardiol. 20 2007 292 298
4. R.A. Kloner, C.E. Ganote, and R.B. Jennings The "no-reflow" phenomenon after temporary coronary occlusion in the dog J. Clin. Invest. 54 1974 1496 1508
5. C. Indolfi, and J. Ross Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching Prog. Cardiovasc. Dis. 36 1993 61 74
6. S. De Rosa, G. Caiazzo, D. Torella, and C. Indolfi Aspiration thrombectomy: an easily forgiven "latecomer" J. Am. Coll. Cardiol. 63 2014 2052 2053
7. O.R. Rosales, B. Eades, and A.R. Assali Cardiovascular drugs: adenosine role in coronary syndromes and percutaneous coronary interventions Catheter. Cardiovasc. Interv. 62 2004 358 363
8. W.B. Hillegass, N.A. Dean, L. Liao, R.G. Rhinehart, and P.R. Myers Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience J. Am. Coll. Cardiol. 37 2001 1335 1343
9. S. De Rosa, G. Caiazzo, D. Torella, and C. Indolfi Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials Int. J. Cardiol. 168 2013 1298 1305
10. S. Zhao, G. Qi, W. Tian, L. Chen, and Y. Sun Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis J. Interv. Cardiol. 27 2014 356 364
11. S. De Rosa, G. Caiazzo, D. Torella, and C. Indolfi What accounts for the higher clinical efficacy of intracoronary abciximab? Int. J. Cardiol. 168 2013 4410
12. M.B. Forman, and E.K. Jackson Importance of tissue perfusion in ST segment elevation myocardial infarction patients undergoing reperfusion strategies: role of adenosine Clin. Cardiol. 30 2007 583 585
13. M. Singh, T. Shah, K. Khosla, P. Singh, J. Molnar, S. Khosla, and et al. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials Ther. Adv. Cardiovasc. Dis. 6 2012 101 114
14. B.J. Burford, V. Welch, E. Waters, P. Tugwell, D. Moher, J. O'Neill, and et al. Testing the PRISMA-equity 2012 reporting guideline: the perspectives of systematic review authors PLoS One 8 2013 e75122 10.1371/journal.pone.007512224130684
15. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J. Natl. Cancer Inst. 22 1959 719 748
16. J.A.C. Sterne, D. Gavaghan, and M. Egger Publication and related bias in meta-analysis: power of statistical tests and prevalence in literature J. Clin. Epidemiol. 53 2000 1119 1129
17. S. De Rosa, D. Torella, G. Caiazzo, S. Giampà, and C. Indolfi Left radial access for percutaneous coronary procedures: from neglected to performer? A meta-analysis of 14 studies including 7,603 procedures Int. J. Cardiol. 171 2014 66 72
18. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
19. M. Grygier, A. Araszkiewicz, M. Lesiak, M. Janus, J. Kowal, W. Skorupski, and et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary Intervention Am. J. Cardiol. 107 2011 1131 1135
20. G. Niccoli, S. Rigattieri, M.R. De Vita, M. Valgimigli, P. Corvo, F. Fabbiocchi, and et al. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction. The REOPEN-AMI study (intracoronary nitroprusside versus adenosine in acute myocardial infarction) J. Am. Coll. Cardiol. Intv. 6 2013 580 589
21. Z.C. Tong, Q. Li, M. Chen, G.B. Miao, Y. Wei, F.O. Li, and et al. [Efficacy comparison of combined intracoronary administration of high dose adenosine and tirofiban versus intracoronary tirofiban during primary percutaneous coronary intervention in patients with acute myocardial infarction] Zhonghua Xin Xue Guan Bing Za Zhi 41 2013 839 844
22. M.L. Fokkema, P.J. Vlaar, M. Vogelzang, Y.L. Gu, M.A. Kampinga, B.J. de Smet, and et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial Circ. Cardiovasc. Interv. 2 2009 323 329
23. W. Desmet, J. Bogaert, C. Dubois, P. Sinnaeve, T. Adriaenssens, and C. Pappas High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction Eur. Heart J. 32 2011 867 877
24. I.F. Akturk, A.A. Yalcin, I. Biyik, C. Sarikamis, N. Turhan Caglar, M. Erturk, and et al. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction Minerva Cardioangiol. 62 2014 389 397
25. M.G. Stoel, K.M. Marques, C.C. de Cock, J.G. Bronzwaer, C. von Birgelen, and F. Zijlstra High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study Catheter. Cardiovasc. Interv. 71 2008 283 289
26. M. Grygier, A. Araszkiewicz, M. Lesiak, and S. Grajek Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up Cardiology 124 2013 199 206
27. A.S. Petronio, M. De Carlo, N. Ciabatti, G. Amoroso, U. Limbruno, C. Palagi, and et al. Left ventricular remodeling after primary coronary angioplasty in patients treated with abciximab or intracoronary adenosine Am. Heart J. 150 2005 1015
28. Z.G. Ji, J.M. Han, G. Liu, and K. Liu Effect of adenosine on ischemia-reperfusion injury during percutaneous coronary intervention CRTER 51 2007 10399 10403
29. D. Garcia-Dorado, B. García-del-Blanco, I. Otaegui, J. Rodríguez-Palomares, V. Pineda, F. Gimeno, and et al. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial Int. J. Cardiol. 177 2014 935 941
30. A. Hendler, A. Aronovich, E. Kaluski, I. Zyssman, Y. Gurevich, A. Blatt, and et al. Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow J. Invasive Cardiol. 18 2006 32 36
31. A. Micari, T.A. Belcik, E.A. Balcells, E. Powers, K. Wei, S. Kaul, and et al. Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting Am. J. Cardiol. 96 2005 1410 1415
32. J. Wang, Y.D. Chen, G. Zhi, Y. Xu, L. Chen, H.B. Liu, and et al. Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction Clin. Exp. Pharmacol. Physiol. 39 2012 247 252
33. H. Zhang, N.L. Tian, Z.Y. Hu, F. Wang, L. Chen, Y.J. Zhang, and et al. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction Chin. Med. J. 125 2012 1713 1719
34. E.P. Navarese, A. Buffon, F. Andreotti, P.A. Gurbel, M. Kozinski, A. Kubica, and et al. Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: a meta-analysis of randomized trials Atherosclerosis 222 2012 1 7
35. M.J. Claeys, J. Bosmans, M. De Ceuninck, A. Beunis, W. Vergauwen, A. Vorlat, and et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction Am. J. Cardiol. 94 2004 9 13
36. R.M. Califf Issues facing clinical trials of the future J. Intern. Med. 254 2003 426 433
37. S. Nakav, C. Chaimovitz, Y. Sufaro, E.C. Lewis, G. Shaked, D. Czeiger, and et al. Anti-inflammatory preconditioning by agonists of adenosine A1 receptor PLoS One 7 2008 3 e2107
38. F. Costa, and I. Biaggioni Role of nitric oxide in adenosine-induced vasodilation in humans Hypertension 31 1998 1061 1064
39. A. Sato, K. Terata, H. Miura, K. Toyama, F.R. Loberiza Jr., O.A. Hatoum, and et al. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease Am. J. Physiol. Heart Circ. Physiol. 288 2005 1633 1640
40. V.E. Pastorova, L.A. Lyapina, and A.M. Ul'anov Antiplatelet effect of adenosine triphosphate administration to animals under different experimental conditions Biol. Bull. 33 2006 488 491
41. L.T. Bune, J.R. Larsen, P. Thaning, N.E. Bune, P. Rasmussen, and J.B. Rosenmeier Adenosine diphosphate reduces infarct size and improves porcine heart function after myocardial infarct Physiol. Rep. 1 2013 e00003 10.1002/PHY2.3
42. P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blömstrom-Lundqvist, M.A. Borger, and et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur. Heart J. 33 2012 2569 2619
43. S. Windecker, P. Kolh, F. Alfonso, J.P. Collet, J. Cremer, V. Falk, and et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI) Eur. Heart J. 35 2014 2541 2619